Tag: Data
First Global Credit Announces Partnership with Financial Industry Data Security Specialist DATAFORT
Nevis – UK – Switzerland (PRWEB) October 20, 2014 First Global Credit Customer Service Ltd., the UK based service division of the company, announced today that they have signed an agreement to work with London based financial industry expert DATAFORT to manage business continuity services for the company. First Global Credit, which allows people to […]
Innovation through Big Data Insights: Utilities and the Future of Data Connectivity
Denver, CO (PRWEB) October 08, 2014 Recently, we had the opportunity to sit down with Michael Schneider to discuss big data analytics, technology innovation and their impact on transforming how utilities do business. In his current role as Vice President of Operations Support for SDG&E and SoCalGas and his former role as VP of Customer […]
Code Green Networks Extends Data Loss Prevention (DLP) for Healthcare to the Cloud
Sunnyvale, CA (PRWEB) September 04, 2014 Code Green Networks, the leading provider of enterprise Data Loss Prevention (DLP) solutions for the Healthcare Industry since 2004, announced that its Data Loss Prevention solution is now available for major cloud storage and collaboration providers and is currently being deployed by leading university hospitals and healthcare systems. […]
Bioinformatics Market: A fusion of Computers and Biological Data
Albany, New York (PRWEB) September 01, 2014 Bioinformatics refers to an interdisciplinary approach to store, retrieve, organize and analyze biological and genetic data. A major part of this field comprises of the activity of developing software tools to generate and process useful biological data. Bioinformatics is not to be confused with biological computation. While bioinformatics […]
Vicus Therapeutics Announces Phase II Data Demonstrating Overall Survival Benefit with VT-122 Plus Sorafenib in Patients with Advanced Hepatocellular Carcinoma
MORRISTOWN, N.J (PRWEB) September 05, 2014 Vicus Therapeutics, an immuno-oncology company focused on bringing breakthrough immunotherapies to patients with solid-tumor cancers, announced positive results from a Phase II randomized, open-label, controlled clinical trial of its lead compound, VT-122, in combination with sorafenib, in patients with advanced hepatocellular carcinoma (HCC). In an intent-to-treat (ITT) population, investigators […]